Biotech Stock Roundup: CGEN Up on GILD Deal, MRNA Gains on Study Data & More
https://www.zacks.com/stock/news/2201158/biotech-stock-roundup-cgen-up-on-gild-deal-mrna-gains-on-study-data-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-2201158
Dec 21, 2023 - Compugen (CGEN) and Moderna (MRNA) are in the news on collaboration and study updates, respectively.
0
MillerKnoll (MLKN) Q2 Earnings Beat Estimates, Up Y/Y, View Up
https://www.zacks.com/stock/news/2201132/millerknoll-mlkn-q2-earnings-beat-estimates-up-y-y-view-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2201132
Dec 21, 2023 - MillerKnoll (MLKN) second-quarter fiscal 2024 results benefit from strategic inventory management, improved gross margins and pricing initiatives.
0
Golar LNG (GLNG) Up 4.6% Since Last Earnings Report: Can It Continue?
https://www.zacks.com/stock/news/2201138/golar-lng-glng-up-4-6-since-last-earnings-report-can-it-continue?cid=CS-ZC-FT-realtime_blog-2201138
Dec 21, 2023 - Golar LNG (GLNG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
0
Why Is Jack In The Box (JACK) Up 15.3% Since Last Earnings Report?
https://www.zacks.com/stock/news/2201145/why-is-jack-in-the-box-jack-up-15-3-since-last-earnings-report?cid=CS-ZC-FT-realtime_blog-2201145
Dec 21, 2023 - Jack In The Box (JACK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
0
Immunovant (IMVT) Up on Upbeat Initial Batoclimab GD Study Data
https://www.zacks.com/stock/news/2201100/immunovant-imvt-up-on-upbeat-initial-batoclimab-gd-study-data?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2201100
Dec 21, 2023 - Immunovant (IMVT) announces positive initial data from the mid-stage study of batoclimab in patients with Graves' disease. The stock gains 12% in the after-market hours, following the news.
0
Company News for Dec 21, 2023
https://www.zacks.com/stock/news/2201004/company-news-for-dec-21-2023?cid=CS-ZC-FT-corporate_summary-2201004
Dec 21, 2023 - Companies in The News Are: UPS, FSLR, AEP, GOOGL
0
Why Novo Nordisk Stock Was Up on a Down Day for the Market
https://www.fool.com/investing/2023/12/20/why-novo-nordisk-stock-was-up-on-a-down-day-for-th/?source=iedfolrf0000001
Dec 20, 2023 - As if the company's top two products weren't popular enough, a new media report made them even more appealing.
0
ITB: Permit Trends Foretold A Surge In Starts And A Home Builder Run-Up - Now What?
https://seekingalpha.com/article/4658868-itb-permit-trends-foretold-a-surge-in-starts-and-a-home-builder-run-up-now-what?source=feed_tag_etf_portfolio_strategy
Dec 20, 2023 - iShares US Home Construction ETF outperformed S&P 500, but extreme price divergence may not be sustainable. Read more on ITB ETF here.
0
Why UPS Stock Was Pulling Back Today
https://www.fool.com/investing/2023/12/20/why-ups-stock-was-pulling-back-today/?source=iedfolrf0000001
Dec 20, 2023 - A disappointing earnings report from FedEx sent shares down at UPS as well.
0
Enersys (ENS) Gives Update on IRC 45X Tax Benefits, Q3 View Up
https://www.zacks.com/stock/news/2200684/enersys-ens-gives-update-on-irc-45x-tax-benefits-q3-view-up?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2200684
Dec 20, 2023 - Enersys (ENS) updates its third-quarter fiscal 2024 outlook, taking into account the impacts of the U.S. Department of the Treasury's proposed regulations regarding Section 45X of the Internal Revenue Code.
0